|
Oral Presentation 9 COVID-19 2 |
08:00-08:50 |
||
|---|---|---|---|
| Chair | |||
| 15:30-15:40 | OP 9-1 |
The Effectiveness of the Use of Regdanvimab in Addition to Remdesivir in Patients with Severe COVID-19: A Single Center Retrospective Study
|
|
| 15:40-15:50 | OP 9-2 |
Usefulness of ROX Index and SpO2/FiO2 Ratio for Predicting High-flow Nasal Cannula Failure in Hypoxemic COVID-19 Patients
|
|
| 15:50-16:00 | OP 9-3 |
Late Failure of High-flow Nasal Cannula May Be Associated with Higher Mortality in COVID-19 Patients: A Multicenter Retrospective Study in Korea
|
|
| 16:00-16:10 | OP 9-4 |
Association between Mechanical Ventilation Management and Outcome in Patients with COVID-19 Acute Respiratory Distress Syndrome: A Retrospective Multicenter Study
|
|
| 16:10-16:20 | OP 9-5 |
Efficacy of Standard Dexamethasone Therapy and Predictors for Non-responsiveness to the Treatment in Patients with COVID-19
|
|
| 16:20-16:30 | OP 9-6 |
Clnical Outcome of COVID-19 Patients with Mechanical Ventilator at Intensive Care Unit
|
|
| 16:30-16:40 | OP 9-7 |
Favorable Outcomes in Critically Ill COVID-19 During Ongoing Pandemic Period
|
|
| 16:40-16:50 | OP 9-8 |
Effect of Bromhexine among COVID-19 Patients - A Meta-anaylsis
|
|
| 16:50-17:00 | OP 9-9 |
Effect of Hyperbaric Oxygen Therapy among COVID-19 Patients: A Meta-analysis
|
|